BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15

• Press Releases

  Oticara Announces Positive Phase 2 Results Demonstrating Durable Symptom Improvement with Novel Steroid Nasal Cream for Hard-to-Treat Post-Surgical Chronic Rhinosinusitis

  October 14, 2025

   · 

  4 min read
• Press Releases

  Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock

  October 14, 2025

   · 

  6 min read
• Press Releases

  Apollomics, Inc. Company Operational Continuity Update

  October 14, 2025

   · 

  6 min read
• Press Releases

  Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  October 14, 2025

   · 

  2 min read
• Press Releases

  Geron Corporation Announces Executive Leadership Transitions and Appointments

  October 14, 2025

   · 

  9 min read
• Press Releases

  EiIean Therapeutics Presents Novel Wild-Type Sparing, Reversible Pan-EGFR Inhibitor (ZE77-0273) with Broad Activity Against Resistance Mutations in EGFR-Mutant NSCLC at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  October 14, 2025

   · 

  1 min read
• Press Releases

  Avantor® Announces Board Chairman Transition

  October 14, 2025

   · 

  4 min read
• Press Releases

  Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference

  October 14, 2025

   · 

  7 min read
• Press Releases

  Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  October 14, 2025

   · 

  7 min read
• Press Releases

  Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome)

  October 14, 2025

   · 

  6 min read